Ajooni Net Debt vs Other Current Liab Analysis

AJOONI Stock

7.54 0.19 2.46%

Ajooni Biotech financial indicator trend analysis is way more than just evaluating Ajooni Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ajooni Biotech is a good investment. Please check the relationship between Ajooni Biotech Net Debt and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajooni Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Debt vs Other Current Liab

Net Debt vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ajooni Biotech Net Debt account and Other Current Liab. At this time, the significance of the direction appears to have weak relationship.

The correlation between Ajooni Biotech's Net Debt and Other Current Liab is 0.33. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Ajooni Biotech Limited, assuming nothing else is changed. The correlation between historical values of Ajooni Biotech's Net Debt and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Ajooni Biotech Limited are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Debt i.e., Ajooni Biotech's Net Debt and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.33

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Other Current Liab

Most indicators from Ajooni Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ajooni Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajooni Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 8.3 M. The current year's Tax Provision is expected to grow to about 5.5 M

	2021	2022	2023	2024 (projected)
Gross Profit	100.2M	87.4M	59.2M	53.7M
Total Revenue	740.4M	744.9M	801.1M	451.3M

Gross Profit Total Revenue

Ajooni Biotech fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Inventory	Other Current Assets	Non Current Liabilities Total	Short Long Term Debt Total	Short Term Debt	Other Assets	Long Term Debt	Short Term Investments
Total Assets		0.73	0.97	0.57	0.9	0.74	0.11	0.13	0.19	0.87	0.74	0.99	0.98	0.2	0.9	0.9	0.02	0.87	0.83	0.68	0.51	0.53	0.31	-0.01	0.76	0.57
Total Current Liabilities	0.73		0.55	0.84	0.51	0.92	0.11	0.13	-0.14	0.37	0.98	0.71	0.63	0.52	0.48	0.77	0.02	0.81	0.33	0.65	0.54	0.89	0.77	-0.07	0.68	0.86
Total Stockholder Equity	0.97	0.55		0.41	0.92	0.59	0.08	0.1	0.26	0.94	0.56	0.97	0.98	0.04	0.94	0.83	-0.01	0.79	0.9	0.61	0.39	0.34	0.1	-0.05	0.7	0.41
Net Debt	0.57	0.84	0.41		0.51	0.75	-0.28	-0.27	0.16	0.24	0.82	0.6	0.5	0.33	0.45	0.5	-0.19	0.76	0.33	0.42	0.44	0.85	0.7	-0.33	0.75	0.74
Retained Earnings	0.9	0.51	0.92	0.51		0.55	-0.04	-0.03	0.42	0.8	0.55	0.94	0.94	-0.1	0.9	0.7	-0.19	0.82	0.86	0.54	0.51	0.37	0.12	0.06	0.76	0.43
Accounts Payable	0.74	0.92	0.59	0.75	0.55		-0.1	-0.07	-0.19	0.41	0.87	0.72	0.66	0.32	0.53	0.76	-0.27	0.86	0.33	0.67	0.37	0.7	0.52	-0.14	0.76	0.91
Cash	0.11	0.11	0.08	-0.28	-0.04	-0.1		1.0	-0.06	0.06	0.16	0.07	0.1	0.15	-0.03	0.18	0.6	-0.07	0.0	0.04	0.29	0.23	0.36	0.62	-0.18	-0.02
Cash And Short Term Investments	0.13	0.13	0.1	-0.27	-0.03	-0.07	1.0		-0.08	0.07	0.18	0.09	0.12	0.17	-0.02	0.2	0.6	-0.05	0.01	0.07	0.3	0.24	0.37	0.61	-0.17	0.0
Common Stock Shares Outstanding	0.19	-0.14	0.26	0.16	0.42	-0.19	-0.06	-0.08		0.32	-0.09	0.29	0.31	-0.45	0.48	-0.03	-0.22	0.19	0.52	-0.4	0.13	0.09	-0.07	-0.09	0.46	-0.16
Other Stockholder Equity	0.87	0.37	0.94	0.24	0.8	0.41	0.06	0.07	0.32		0.36	0.86	0.89	0.01	0.94	0.7	0.03	0.59	0.94	0.4	0.25	0.14	-0.1	-0.16	0.59	0.16
Total Liab	0.74	0.98	0.56	0.82	0.55	0.87	0.16	0.18	-0.09	0.36		0.71	0.63	0.56	0.5	0.78	0.08	0.78	0.38	0.61	0.71	0.88	0.78	0.09	0.64	0.8
Total Current Assets	0.99	0.71	0.97	0.6	0.94	0.72	0.07	0.09	0.29	0.86	0.71		0.99	0.09	0.93	0.85	-0.07	0.89	0.85	0.61	0.49	0.54	0.29	-0.04	0.82	0.57
Common Stock	0.98	0.63	0.98	0.5	0.94	0.66	0.1	0.12	0.31	0.89	0.63	0.99		0.01	0.94	0.83	-0.07	0.86	0.87	0.6	0.44	0.45	0.21	-0.01	0.79	0.52
Other Current Liab	0.2	0.52	0.04	0.33	-0.1	0.32	0.15	0.17	-0.45	0.01	0.56	0.09	0.01		-0.06	0.45	0.59	0.08	-0.02	0.37	0.47	0.42	0.54	0.02	-0.11	0.16
Property Plant And Equipment Net	0.9	0.48	0.94	0.45	0.9	0.53	-0.03	-0.02	0.48	0.94	0.5	0.93	0.94	-0.06		0.68	-0.15	0.72	0.96	0.34	0.39	0.32	0.04	-0.14	0.77	0.32
Non Current Assets Total	0.9	0.77	0.83	0.5	0.7	0.76	0.18	0.2	-0.03	0.7	0.78	0.85	0.83	0.45	0.68		0.19	0.82	0.61	0.79	0.52	0.55	0.41	0.07	0.61	0.62
Non Currrent Assets Other	0.02	0.02	-0.01	-0.19	-0.19	-0.27	0.6	0.6	-0.22	0.03	0.08	-0.07	-0.07	0.59	-0.15	0.19		-0.25	0.01	0.12	0.24	0.11	0.33	0.26	-0.47	-0.26
Net Receivables	0.87	0.81	0.79	0.76	0.82	0.86	-0.07	-0.05	0.19	0.59	0.78	0.89	0.86	0.08	0.72	0.82	-0.25		0.56	0.71	0.39	0.69	0.46	-0.11	0.9	0.83
Inventory	0.83	0.33	0.9	0.33	0.86	0.33	0.0	0.01	0.52	0.94	0.38	0.85	0.87	-0.02	0.96	0.61	0.01	0.56		0.26	0.44	0.19	-0.05	-0.07	0.6	0.1
Other Current Assets	0.68	0.65	0.61	0.42	0.54	0.67	0.04	0.07	-0.4	0.4	0.61	0.61	0.6	0.37	0.34	0.79	0.12	0.71	0.26		0.26	0.41	0.34	0.03	0.37	0.61
Non Current Liabilities Total	0.51	0.54	0.39	0.44	0.51	0.37	0.29	0.3	0.13	0.25	0.71	0.49	0.44	0.47	0.39	0.52	0.24	0.39	0.44	0.26		0.52	0.49	0.57	0.27	0.29
Short Long Term Debt Total	0.53	0.89	0.34	0.85	0.37	0.7	0.23	0.24	0.09	0.14	0.88	0.54	0.45	0.42	0.32	0.55	0.11	0.69	0.19	0.41	0.52		0.94	-0.05	0.63	0.76
Short Term Debt	0.31	0.77	0.1	0.7	0.12	0.52	0.36	0.37	-0.07	-0.1	0.78	0.29	0.21	0.54	0.04	0.41	0.33	0.46	-0.05	0.34	0.49	0.94		0.07	0.34	0.64
Other Assets	-0.01	-0.07	-0.05	-0.33	0.06	-0.14	0.62	0.61	-0.09	-0.16	0.09	-0.04	-0.01	0.02	-0.14	0.07	0.26	-0.11	-0.07	0.03	0.57	-0.05	0.07		-0.29	-0.03
Long Term Debt	0.76	0.68	0.7	0.75	0.76	0.76	-0.18	-0.17	0.46	0.59	0.64	0.82	0.79	-0.11	0.77	0.61	-0.47	0.9	0.6	0.37	0.27	0.63	0.34	-0.29		0.7
Short Term Investments	0.57	0.86	0.41	0.74	0.43	0.91	-0.02	0.0	-0.16	0.16	0.8	0.57	0.52	0.16	0.32	0.62	-0.26	0.83	0.1	0.61	0.29	0.76	0.64	-0.03	0.7

Click cells to compare fundamentals

Ajooni Biotech Account Relationship Matchups

Ajooni Biotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	230.7M	280.3M	290.2M	587.3M	475.2M	499.0M
Total Current Liabilities	58.5M	104.8M	100.6M	152.1M	30.1M	58.3M
Total Stockholder Equity	158.9M	156.5M	163.8M	416.7M	427.1M	448.4M
Net Debt	49.0M	65.4M	52.9M	48.7M	17.4M	25.9M
Retained Earnings	63.6M	44.5M	55M	66.2M	86.9M	91.3M
Accounts Payable	19.3M	54.0M	68.0M	101.1M	15.8M	29.2M
Cash	1.2M	2.4M	573.9K	3.1M	4.3M	7.0M
Cash And Short Term Investments	1.2M	2.4M	573.9K	4.9M	4.3M	7.1M
Common Stock Shares Outstanding	38.6M	53.0M	56.7M	5.8M	86.4M	47.5M
Liabilities And Stockholders Equity	230.7M	280.3M	290.2M	587.3M	475.2M	499.0M
Other Stockholder Equity	11.3M	30.1M	63.8M	178.0M	264.9M	278.1M
Total Liab	71.8M	123.8M	126.4M	170.6M	48.1M	76.7M
Total Current Assets	175.1M	214.3M	219.3M	346.7M	323.3M	339.4M
Common Stock	61.6M	84.1M	100.1M	175.2M	175.2M	184.0M
Other Current Liab	499.6K	381.4K	333.1K	11.2M	570K	541.5K
Property Plant And Equipment Net	20.7M	51.6M	62.1M	65.5M	112.4M	118.1M
Non Current Assets Total	55.6M	66.0M	70.9M	240.6M	151.9M	80.7M
Non Currrent Assets Other	2.8M	1.4M	(69.1M)	15M	15.0M	8.0M
Net Receivables	129.1M	138.7M	139.4M	205.5M	129.6M	85.3M
Inventory	32.9M	53.8M	58.8M	69.9M	180.6M	189.6M
Other Current Assets	141.0M	11.5M	12.7M	268.6M	34.6M	58.8M
Non Current Liabilities Total	13.3M	19.0M	25.8M	18.5M	18.0M	22.0M
Short Long Term Debt Total	50.3M	67.8M	53.5M	51.8M	21.7M	20.6M
Short Term Debt	36.9M	48.9M	27.7M	34.3M	4.9M	4.6M
Long Term Debt	13.3M	19.0M	25.8M	17.5M	20.1M	12.4M
Short Term Investments	661K	1.6M	1.2M	1.8M	22K	20.9K
Long Term Debt Total	13.3M	19.0M	25.8M	17.5M	20.1M	13.5M
Property Plant Equipment	20.7M	51.6M	62.1M	65.5M	75.3M	79.1M
Net Tangible Assets	158.9M	156.5M	163.8M	416.7M	479.2M	503.2M
Current Deferred Revenue	1.9M	1.5M	4.5M	5.7M	83K	78.9K
Net Invested Capital	209.2M	224.3M	217.3M	468.5M	538.7M	274.7M
Short Long Term Debt	36.9M	48.9M	27.7M	34.3M	39.4M	33.9M
Non Current Liabilities Other	(0.13)	0.32	0.11	(1.0)	(0.9)	(0.85)
Net Working Capital	116.6M	109.5M	118.7M	194.6M	223.8M	140.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Ajooni Stock

Balance Sheet is a snapshot of the financial position of Ajooni Biotech at a specified time, usually calculated after every quarter, six months, or one year. Ajooni Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ajooni Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ajooni currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ajooni Net Debt vs Other Current Liab Analysis

Net Debt vs Other Current Liab

Net Debt vs Other Current Liab Correlation Analysis

Correlation Coefficient

Net Debt

Other Current Liab

Ajooni Biotech fundamental ratios Correlations

Ajooni Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ajooni Biotech fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Ajooni Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Common Stock	+ 0.99	Total Current Assets
Common Stock	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Current Liabilities
Common Stock	+ 0.98	Total Stockholder Equity

Long Term Debt	- 0.47	Non Currrent Assets Other
Other Current Liab	- 0.45	Common Stock Shares Outstanding
Other Current Assets	- 0.4	Common Stock Shares Outstanding
Other Assets	- 0.33	Net Debt
Long Term Debt	- 0.29	Other Assets
Cash	- 0.28	Net Debt